首页> 外文期刊>Experimental and clinical transplantation >Liver Transplant in a Patient with Active Pulmonary Tuberculosis
【24h】

Liver Transplant in a Patient with Active Pulmonary Tuberculosis

机译:活动性肺结核患者的肝移植

获取原文
           

摘要

Objectives: Immunosuppressive treatment generally increases the severity of active infection. Therefore, liver transplant is contraindicated in the presence of active tuberculosis. Despite the importance of supportive treatment, liver transplant is the only treatment for fulminant hepatic failure. Materials and Methods: We report a case of successful liver transplant for fulminant hepatic failure in the presence of active tuberculosis infection. Results: We immediately performed a liver transplant from a live donor. The patient received low-dose immunosuppressive treatment and antituberculosis treatment. The patient was cured and discharged on the 25th day after surgery. We stopped antituberculosis treatment 10 months after discharge. The patient has been followed for 32 months after transplant with normal graft function and has been free of pulmonary tuberculosis infection. Conclusions: Liver transplant can be performed in cirrhotic patients with active infections, such as tuberculosis, as a life-saving procedure.
机译:目的:免疫抑制治疗通常会增加活动性感染的严重程度。因此,在活动性结核病的存在下,肝移植是禁忌的。尽管支持治疗很重要,但肝移植是暴发性肝衰竭的唯一治疗方法。材料和方法:我们报道了在存在活动性结核感染的情况下,因暴发性肝衰竭成功进行肝移植的病例。结果:我们立即从活体供体进行了肝移植。该患者接受了小剂量免疫抑制治疗和抗结核治疗。病人在手术后第25天day愈出院。出院10个月后,我们停止了抗结核治疗。移植后患者随访32个月,移植功能正常,无肺结核感染。结论:肝移植可在具有活动性感染(例如结核)的肝硬化患者中进行,以挽救生命。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号